Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit

Clin Infect Dis. 2007 Aug 15;45(4):521-3. doi: 10.1086/520010.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ceftazidime / administration & dosage*
  • Ceftazidime / adverse effects
  • Ceftazidime / therapeutic use
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Humans
  • Infusions, Parenteral
  • Melioidosis / drug therapy*
  • Treatment Outcome
  • Trimethoprim, Sulfamethoxazole Drug Combination / administration & dosage*
  • Trimethoprim, Sulfamethoxazole Drug Combination / adverse effects
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use

Substances

  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Ceftazidime